David J Pollard

Title: David J Pollard: Innovator in Bioreduction Technology

Introduction

David J Pollard is a notable inventor based in Monroe Township, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the area of enantioselective bioreduction. His work has implications for the development of pharmaceutical compounds, showcasing the intersection of innovation and practical application in medicine.

Latest Patents

David J Pollard holds a patent titled "Enantioselective bioreduction for the preparation of integrin receptor antagonist intermediates." This invention relates to a novel enantioselective bioreduction process using a yeast microorganism. The process is designed for the preparation of chiral allylic alcohols, which are useful in the asymmetric synthesis of integrin αvβ receptor antagonists. He has 1 patent to his name, reflecting his focused contributions to this specialized area of research.

Career Highlights

Pollard is associated with Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to work on innovative solutions that address complex challenges in drug development. His expertise in biochemistry and patentable inventions has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Joseph Nti-Gyabaah and James Christopher McWilliams. These collaborations have likely enhanced the scope and impact of his research, fostering an environment of shared knowledge and innovation.

Conclusion

David J Pollard exemplifies the spirit of innovation in the field of biochemistry. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic agents. His work continues to influence the pharmaceutical landscape, paving the way for future advancements.